Skip to main content
CMS to let MA plans negotiate lower prices for Part B drugs

The CMS announced Tuesday that it will be allowing Medicare Advantage plans to negotiate lower prices for doctor-administered drugs covered under Part B as part of the Trump administration's broader effort to cut prescription drug costs. Effective next year, MA plans will be permitted to use a cost-saving tool called step therapy, which gives payers the option to offer patients the most-preferred and often least expensive therapy first, before moving them to a more expensive drug if the initial treatment is not effective.

Full Story: